LANI, ELISA
 Distribuzione geografica
Continente #
EU - Europa 180
NA - Nord America 172
AS - Asia 124
SA - Sud America 14
AF - Africa 12
Totale 502
Nazione #
US - Stati Uniti d'America 169
GB - Regno Unito 51
SG - Singapore 49
DE - Germania 33
CN - Cina 31
SE - Svezia 24
IT - Italia 21
HK - Hong Kong 18
BR - Brasile 10
RU - Federazione Russa 10
VN - Vietnam 10
FR - Francia 9
NL - Olanda 8
IN - India 7
IE - Irlanda 6
AR - Argentina 4
EE - Estonia 4
JO - Giordania 4
NG - Nigeria 4
UA - Ucraina 4
ZA - Sudafrica 4
CA - Canada 3
FI - Finlandia 3
TG - Togo 3
CH - Svizzera 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
TW - Taiwan 1
Totale 502
Città #
Southend 46
Singapore 30
Ashburn 23
Hong Kong 18
Santa Clara 15
Fairfield 13
Houston 10
Chandler 9
Beijing 8
Princeton 8
Dublin 6
Boardman 5
Cambridge 5
Nanjing 5
Padova 5
Wilmington 5
Abeokuta 4
Amman 4
Bologna 4
Medford 4
Munich 4
Seattle 4
Westminster 4
Ann Arbor 3
Bremen 3
Duque de Caxias 3
Falkenstein 3
Frankfurt am Main 3
Lomé 3
Redondo Beach 3
São Paulo 3
Tappahannock 3
Woodbridge 3
Bern 2
Hanoi 2
Ho Chi Minh City 2
Montreal 2
Nanchang 2
Paris 2
Portsmouth 2
Turku 2
Yubileyny 2
Abidjan 1
Baoding 1
Berlin 1
Cleveland 1
Cà Mau 1
Da Nang 1
Dallas 1
Dubai 1
Düsseldorf 1
Falls Church 1
General Arenales 1
Hebei 1
Helsinki 1
Henderson 1
Janaúba 1
Jerusalem 1
Jiangmen 1
Jiaxing 1
Jinan 1
Kraków 1
Long Khánh Một 1
Los Angeles 1
Manchester 1
Milan 1
Mountain View 1
Nuremberg 1
Olalla 1
Osnago 1
Portici 1
Quilmes 1
Saint Petersburg 1
San Luis 1
Serrinha 1
Shanghai 1
Shenyang 1
Shiraz 1
Sofia 1
Stockholm 1
Suzano 1
São Gonçalo 1
Taipei 1
Tokyo 1
Toronto 1
Victoria 1
Vienna 1
Vladivostok 1
Vĩnh Phúc Province 1
Vĩnh Tường 1
Xian 1
Đồng Nai Province 1
Totale 337
Nome #
Ponatinib Is Well Tolerated and Active In Patients With Relapsed/Refractory Philadelphia Positive Acute Lymphoblastic Leukemia (PH+ ALL) and Advanced Phase Of Chronic Myelogenous Leukemia (CML) Harbouring T315I Mutation: The Bologna Experience 146
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome 135
Ponatinib is well tolerated and active in patients with relapsed/refractory philadelphia positive leukemias: The Bologna experience 118
PKC412 (Midostaurin) is safe and highly effective in Systemic Mastocytosis patients: follow up of a single-center Italian compassionate use 114
Totale 513
Categoria #
all - tutte 1.455
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.455


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 1 0 0 5 1 1 6
2021/202269 5 2 4 8 8 2 0 3 1 6 17 13
2022/202373 7 8 1 10 9 5 1 3 19 1 7 2
2023/202418 0 6 1 1 1 2 3 0 1 1 0 2
2024/2025115 7 20 6 5 15 2 5 5 0 14 4 32
2025/202686 20 9 15 5 30 7 0 0 0 0 0 0
Totale 513